Vincent Algalarrondo

Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy

Marianna Fontana, John L. Berk, Julian D. Gillmore et al. · New England Journal of Medicine · 2024 · 362 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +11

Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study

Jonathan P. Piccini, Valeria Caso, Stuart J. Connolly et al. · The Lancet · 2022 · 311 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +11

Extracorporeal cardiopulmonary resuscitation in out-of-hospital cardiac arrest: a registry study

Wulfran Bougouin, Florence Dumas, Lionel Lamhaut et al. · European Heart Journal · 2019 · 285 citations · Full text

Medicine, Surgery, Cardiothoracic Surgery +12

Genotype–phenotype correlation and course of transthyretin familial amyloid polyneuropathies in France

Louise‐Laure Mariani, Pierre Lozeron, Marie Théaudin et al. · Annals of Neurology · 2015 · 186 citations · Full text

Medicine, Neurology, Medical Genetics +15

Long-term safety and efficacy of patisiran for hereditary transthyretin-mediated amyloidosis with polyneuropathy: 12-month results of an open-label extension study

David Adams, Michael Polydefkis, Alejandra González‐Duarte et al. · The Lancet Neurology · 2020 · 156 citations

Medicine, Neurology, Pharmacotherapy +14